MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Myriad Genetics Long Term Debt Current 2011-2026 | MYGN
Annual Long Term Debt Current Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.8 M | 16.2 M | 14.1 M | 13 M | 13.6 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 M | 12.8 M | 13.9 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 22.96 | -0.56 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M |  USA |
 |
Danaher Corporation
DHR
|
173 M | $ 237.64 | 1.12 % | $ 174 B | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 12.15 | -5.81 % | $ 345 M | Israel |
 |
DexCom
DXCM
|
21.1 M | $ 66.95 | -2.16 % | $ 25.8 B | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.59 | -0.94 % | $ 2.02 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
838 K | $ 6.12 | - | $ 180 M | USA |
 |
IQVIA Holdings
IQV
|
99 M | $ 243.33 | 0.06 % | $ 44.1 B | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 39.59 | -0.76 % | $ 1.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
7.64 M | $ 234.65 | -2.05 % | $ 23.1 B | USA |
 |
CareDx, Inc
CDNA
|
5.94 M | $ 17.02 | -1.16 % | $ 915 M | USA |
 |
Celcuity
CELC
|
172 K | $ 107.43 | 2.63 % | $ 4.24 B | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
9.59 M | $ 1.95 | -4.66 % | $ 495 M | USA |
 |
Anixa Biosciences
ANIX
|
29 K | $ 3.41 | -0.29 % | $ 109 K | USA |
 |
Exact Sciences Corporation
EXAS
|
27.4 M | $ 102.13 | 0.34 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 27.84 | -0.2 % | $ 842 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | $ 48.32 | -0.27 % | $ 10.8 B |  Niderland |
 |
RadNet
RDNT
|
56.6 M | $ 77.42 | -1.22 % | $ 5.65 B | USA |
 |
Guardant Health
GH
|
29.2 M | $ 110.18 | 1.32 % | $ 13.5 B | USA |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
79 M | $ 141.01 | -3.31 % | $ 22.4 B | USA |
 |
Charles River Laboratories International
CRL
|
54.2 M | $ 220.64 | 2.38 % | $ 11.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
261 M | $ 620.69 | 2.34 % | $ 237 B | USA |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 35.58 | 2.42 % | $ 2.13 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
173 M | $ 175.1 | -1.49 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
719 K | $ 5.46 | -2.15 % | $ 708 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
185 M | $ 252.61 | -0.81 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 183.13 | -2.7 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
21.5 M | $ 715.47 | 0.43 % | $ 59 B | USA |
 |
Lantheus Holdings
LNTH
|
1.87 M | $ 67.98 | 0.19 % | $ 4.7 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.75 | -4.84 % | $ 6.32 M | USA |
 |
Bioventus
BVS
|
4.06 M | $ 8.02 | 0.25 % | $ 502 M | USA |